Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic nucleotide-binding domain-containing protein 1 (CNBD1) is a human protein characterized by the presence of a cyclic nucleotide-binding domain, a structural motif known for binding signaling molecules such as cAMP and cGMP. While many proteins with this domain are involved in signal transduction (like kinases and ion channels), CNBD1 itself has no characterized biological function or disease association as of current research and protein annotation databases. It is typically considered within the broader family of cyclic nucleotide-binding proteins but is not a clinically validated therapeutic target. The domain structure suggests potential for cyclic nucleotide interaction, though specific ligands, biological roles, and clinical relevance remain undefined. Additional context: - The cyclic nucleotide-binding domain is common in critical proteins, including protein kinases and certain ion channels; however, CNBD1's individual role is not delineated. - Other proteins with this domain, such as cAMP-dependent protein kinase (PKA), are well studied and implicated in diseases, but CNBD1 is not currently included among these functional targets. If you need information on structurally or functionally related targets (such as cAMP-dependent protein kinase or cyclic nucleotide-gated channels), many have established clinical, biological, and pharmacological significance. CNBD1 itself remains an uncharacterized protein with inferred general function from domain analysis.
Not applicable; mechanisms of drug action are not established for CNBD1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic nucleotide-binding domain-containing protein 1 (CNBD1).